8/9/2013 6:46:51 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Anacor Pharmaceuticals (NASDAQ:ANAC) announced today its financial results for the second quarter ended June 30, 2013.
“We had a busy second quarter as we finalized preparations for our NDA for tavaborole, which was submitted on July 26th. This is an exciting time at Anacor as we begin to reap the benefits of the investments that we’ve made in drug development over the last decade and plan the commercialization of our later stage products,” said David Perry, Chief Executive Officer of Anacor Pharmaceuticals.
Hey, check out all the engineering jobs. Post your resume today!
comments powered by